Outcome of Omani Women with Breast Cancer-associated Brain Metastases Experience from a University Hospital
Journal Title: Oman Medical Journal - Year 2019, Vol 34, Issue 5
Abstract
Objectives: Breast cancer (BC) is the leading cancer among women. Almost 20% of patients develop brain metastases (BM) and die shortly afterward. There is a dearth of data on the survival outcome of BC patients with BM from the Arab world. Methods: Consecutive women diagnosed with BC who developed radiologically-confirmed BM during their illness were identified through the hospital’s electronic patient’s records. Clinicopathological features and treatment outcomes were recorded. Survival was calculated using the Kaplan-Meier method, and factors affecting survival were studied using log-rank analysis. Results: Between January 2003 and June 2015, a total of 692 patients were treated for BC at our institute. Forty-eight (6.9%) developed BM. The median age at the diagnosis of BM was 45.2 years. More than half of cohort (54.2%) had HER2 positive disease, while 27.1% had the triple-negative disease. The median time interval between the diagnosis of BC and the development of BM was 21 months, and median survival after development of brain disease was seven months. On univariate analysis, pathological grade, previous systemic treatment, brain as the first site of metastases, brain as the only site of metastases, treatment of BM, systemic treatment after BM, and diagnosis-specific graded prognostic assessment (DS-GPA) score significantly affected survival. On multivariate Cox regression analysis, the brain as the first site of metastases, treatment for brain disease, treatment type, and DS-GPA score significantly affected survival post-BM. Conclusions: Our data indicate that Omani women are diagnosed with BC at a younger age, develop BM earlier, and carry a poor outcome.
Authors and Affiliations
Khawaja F. Zahid, Shiyam Kumar, Khalid Al-Bimani, Tanweer Ahmed, Adil Al-Ajmi, Ikram A. Burney, Mansour Al-Moundhri
Keywords
Related Articles
- EP ID EP634686
- DOI 10.5001/omj.2019.76
- Views 92
- Downloads 0
How to Discriminate Between Primary Hepatic Lymphoma and Cholangiocarcinoma
W read the report on ‘Primary Hepatic Lymphoma Mimicking Cholangiocarcinoma’ published in the July 2017 issue of the Oman Medical Journal with great interest. In fact, both primary hepatic lymphoma and cholangiocarcinoma...
A Case of Isolated Septal Myocardial Infarction: Myocardial Perfusion-Metabolism Mismatch as a Tool for Diagnosis
Isolated septal myocardial infarction is an uncommon condition with diagnostic difficulty due to small infarction size and anatomical variations. We report a case of isolated septal myocardial infarction, in which the di...
Foreign Body Ingestion in Children: The Role of X-ray
Iread with great interest the retrospective review of foreign body ingestion among Omani children published in the November 2018 issue of the Oman Medical Journal. Of the 585 patients reviewed, 385 were enrolled based on...
Gdn3+@CNTs-PEG versus Gadovist®: In Vitro Assay
Objectives: Carbon nanotubes (CNTs) are allotropes of carbon with a length-to-diameter ratio greater than 106 with the potential uses as medical diagnostic or therapeutic agents. In vitro studies have revealed that gadol...
Skin Substitutes: A Brief Review of Types and Clinical Applications<br />
Replacing skin defects has witnessed several developments over the centuries. It started with the introduction of skin grafting by Reverdin in 1871...